BioCentury
ARTICLE | Financial News

RuiYi raises $15 million in B round

March 28, 2014 12:50 AM UTC

RuiYi Inc. (La Jolla, Calif.) raised $15 million in a series B round from existing investors 5AM Ventures; Versant Ventures; Apposite Capital; SR One; MS Ventures; and Aravis Venture. RuiYi also hired Erik Karrer as CSO. He was head of molecular biology and discovery at Perseid Therapeutics LLC, a former unit of Astellas Pharma Inc. (Tokyo:4503). ...